Wildcat Capital Management

Latest statistics and disclosures from Wildcat Capital Management's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Wildcat Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Wildcat Capital Management

Wildcat Capital Management holds 8 positions in its portfolio as reported in the December 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Frontier Group Hldgs (ULCC) 79.0 $200M 28M 7.11
 View chart
Rlx Technology Sponsored Ads (RLX) 15.4 $39M 18M 2.16
 View chart
Allogene Therapeutics (ALLO) 2.5 $6.2M 2.9M 2.13
 View chart
Urogen Pharma (URGN) 2.1 $5.3M 496k 10.65
 View chart
Kronos Bio (KRON) 0.5 $1.2M 1.3M 0.95
 View chart
Gitlab Class A Com (GTLB) 0.3 $642k NEW 11k 56.35
 View chart
Procore Technologies (PCOR) 0.2 $607k NEW 8.1k 74.93
 View chart
Silexion Therapeutics Corp Shs New 0.1 $228k NEW 113k 2.01
 View chart

Past Filings by Wildcat Capital Management

SEC 13F filings are viewable for Wildcat Capital Management going back to 2014

View all past filings